Neurocrine Biosciences, Inc. Profile Avatar - Palmy Investing

Neurocrine Biosciences, Inc.

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibr…
Drug Manufacturers - Specialty & Generic
US, San Diego [HQ]

News

Theses · Events · Sentiments
End of NBIX's Analysis
CIK: 914475 CUSIP: 64125C109 ISIN: US64125C1099 LEI: - UEI: -
Secondary Listings
NBIX has no secondary listings inside our databases.